8/20/2013 7:52:51 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Apparently not everyone is having success pitching a biotech IPO to investors these days. Basking Ridge, NJ-based Regado Biosciences, the startup developing a two-pronged anticoagulant to be used in coronary procedures, is slashing the price of its IPO considerably. Regado initially aimed to raise $75 million by offering investors 5 million shares at between $14 and $16 apiece.
Help employers find you! Check out all the jobs and post your resume.
comments powered by